Results 81 to 90 of about 94,533 (302)

Stability Analysis of Hepatitis B Virus Model with Incomplete Immunization of HepB Vaccine [PDF]

, 2014
Yan Cheng, Qiuhui Pan, Mingfeng He
openalex   +1 more source

Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 420-434, March 2025.
ABSTRACT Chronic Hepatitis B presents a significant health and socioeconomic burden. The risk of hepatocellular carcinoma remains elevated although treatments are available. Achieving an optimal treatment regimen necessitates a deep comprehension of the dynamic relationship between the virus and its host across disease states.
Clémence Boivin‐Champeaux, Nieves Velez de Mendizabal, Aksana Jones, Scott Balsitis, Stephan Schmidt, Justin S. Feigelman, Francine Johansson Azeredo   +6 more
wiley   +1 more source

Factors influencing the utilisation of anti-HBs titre testing services among nursing students in Northwest Ghana: A cross-sectional study.

PLOS Global Public Health
Understanding the impact of hepatitis B testing, vaccination, the number of vaccine doses, and socio-demographics on post-vaccination anti-HBs titre testing, is essential for hepatitis B prevention. The aim of the study was to determine the prevalence of
Augustine Ngmenemandel Balegha
doaj   +1 more source

Survey of vaccination practices in patients with diabetes: A report examining patient and provider perceptions and barriers

Journal of Clinical & Translational Endocrinology, 2017
In a cross-sectional study involving 279 patients with diabetes attending a primary care center the proportion of patients vaccinated for seasonal influenza, pneumococcus and hepatitis B was 40%, 2% and 2%, respectively. We found significant barriers for
Carlos E. Alvarez, Luciana Clichici, Angela Patricia Guzmán-Libreros, Mariola Navarro-Francés, Javier Ena   +4 more
doaj   +1 more source

Progress in coverage with hepatitis B vaccine among US children, 1994-1997. [PDF]

, 1999
H. Yusuf, Victor G. Coronado, F A Averhoff, E F Maes, Lance E. Rodewald, Maurizio Battaglia, Francis J. Mahoney   +6 more
openalex   +1 more source

Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing

Small, EarlyView.
The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa, Mamata Karmacharya, Hyunmin Choi, Sumit Kumar, Yoon‐Kyoung Cho   +4 more
wiley   +1 more source

Synergistic and Additive Effects of Cimetidine and Levamisole on Cellular Immune Responses to Hepatitis B virus DNA Vaccine in Mice [PDF]

, 2013
Xinli Niu, Ye Yang, J. Wang
openalex   +1 more source

Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda

, 2021
Emmanuel Seremba, Ponsiano Ocama, Richard Ssekitoleko, Harriet Mayanja‐Kizza, Scott V. Adams, Jackson Orem, Elly Katabira, Steven J. Reynolds, Rose Nabatanzi, Corey Casper, Warren Phipps   +10 more
openalex   +2 more sources

Novel Wide‐Spectrum Virucidal Lipid Nanoparticles

Small, EarlyView.
POSTAN is a novel broad‐spectrum antiviral nanoparticle that combines safety with potent virucidal activity. Composed of biocompatible lipids, it mimics heparan sulfate proteoglycans and lipid rafts exploited by viruses, thereby dismantling viral envelopes and blocking replication.
Yugo Araújo Martins, Louise Bondeelle, Arnaud Charles‐Antoine Zwygart, Thais Melquiades de Lima, Juliano de Paula Souza, Han Kang Tee, Fernando Chahud, Eurico de Arruda Neto, Francesco Stellacci, Renata Fonseca Vianna Lopez, Caroline Tapparel   +10 more
wiley   +1 more source

Hepatitis B virus vaccines: Some cryptic issues [PDF]

, 1998
Subhash C. Arya
openalex   +1 more source